(01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type Consolidate Consolidate Consolidate Consolidate Revenue From Operations 226.35 471.00 1,805.80 1,929.50 Other Income 20.40 41.06 43.51
Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type Consolidate Consolidate Consolidate
(MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type Consolidate Consolidate Consolidate Consolidate Revenue From
Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) Accounting Type Consolidate Consolidate Consolidate Revenue From Operations
/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18 -31/12/18) Accounting Type Consolidate Consolidate Company Company Revenue From Operations 2,098.09 1,806.35 2,055.48 1,940.22 Other Income 38.49
: Value of Acquisition of Assets, compared to value of total Assets of the Company by comparing with actual buy and sell price of the land nearby 12. Transaction Size : Equivalent to 17.82% of the Company’s
and nearby countries Objectives of Investment 1. To increase production capability and shorten lead time for sales to customers in the US and nearby countries 2. To expand distribution network in the
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
143,840,400 and actual buying & selling price of the land that is located nearby which is approximate Bath 276,912,000 - 338,448,000 by the company using the maximum price is the price of the actual trading of
the three-month period ended March 31, 2020, which have been reviewed by the auditor as follows: Consolidate Financial Statements Unit : Million Baht For the periods ended March 31, 2020 2019 REVENUES